Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.

Authors :: Martínez-Zamora MA
Creus M
Tassies D
Bové A
Reverter JC
Carmona F
Balasch J
Source :: Fertility and sterility [Fertil Steril] 2010 Nov; Vol. 94 (6), pp. 2437-40. Date of Electronic Publication: 2010 Apr 07.
Publication Year :: 2010
Abstract: Antiphospholipid syndrome patients with recurrent miscarriage have an impairment in fibrinolysis demonstrated by prolonged clot lysis time (CLT) that cannot be attributed to differences in thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels. Patients with unexplained recurrent miscarriage have an impairment in fibrinolysis demonstrated by increased CLT, that can be at least partly explained by higher TAFI antigen levels.<br /> (Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)

Subjects :: Abortion, Habitual etiology
Adult
Antiphospholipid Syndrome complications
Blood Coagulation physiology
Blood Coagulation Tests
Carboxypeptidase B2 analysis
Case-Control Studies
Female
Fibrinolysis physiology
Humans
Pregnancy
Time Factors
Abortion, Habitual blood
Antiphospholipid Syndrome blood
Carboxypeptidase B2 blood

Full Text Access

Tools